Device maker Acandis said it has received the CE Mark for its Aperio hybrid stent retriever.
Aperio is designed for efficient clot retention and fast arterial flow restoration in ischemic stroke patients with a large intracranial blood clot, according to the Pforzheim, Germany-based company.
“Our engineers combined the proven, reliable and
effective hybrid cell design with a new visibility concept for more safety and control,” said Acandis CEO Andreas Schuessler in a news release. “The radiopaque DFT wires allow excellent full-length visibility of the device for precise alignment and permanent control during the procedure.”
Aperio is designed for vessel diameters from 1.5 mm up to 5.5 mm and can be delivered through common 0.021’’ microcatheters, according to Acandis. The company also offers microcatheters and intermediate catheters for the treatment of ischemic stroke.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!